In Follow Up
Maritime-1
In Follow Up, Weight Loss
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight…
Redefine-3
In Follow Up, Weight Loss
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with…
Shasta-4
In Follow Up, High Triglyceride
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe…
MUIR-3
In Follow Up, High Triglyceride
This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia…
Triumph
In Follow Up, Weight Loss
The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and chronic…
V-Prevent
In Follow Up, Cholesterol
The purpose of this study is to evaluate inclisiran sodium 300 mg s.c. (equivalent to 284 mg inclisiran) compared to placebo on reducing the…
Merck Cholesterol
In Follow Up, Cholesterol
The goal of this study is to evaluate the efficacy, safety, and tolerability of MK-0616 in adult participants with hypercholesterolemia. The…
Ocean (a)
In Follow Up, Lipoprotein (a)
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease…
Surmount-MMO
In Follow Up, Weight Loss
This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide…
Azalea A Fib
In Follow Up
The purpose of the ANT-006 study is to evaluate the bleeding profile of abelacimab relative to rivaroxaban in patients with atrial…
Orion
In Follow Up, Cholesterol
ORION-4 is a research study coordinated by the University of Oxford and co-sponsored by The University of Oxford and Novartis (Protocol…